MNKD · Healthcare · $1.2B
$3.90+16.77%
What's this stock's score right now?
See its score for free — revenue and money flow, graded on one standard.
Quarterly Financials
9/'26
6/'26 vs prev quarter
Among 327 Biotechnology peers
Quarterly Revenue Growth
“경영진이 가장 강조한 건 '2026년이 회사 역사상 가장 바쁜 전환점'이라는 점이에요.”
In the company's words · 2026 1분기 earnings call